CABA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cabaletta Bio Inc (CABA) is not a strong buy for a beginner, long-term investor at this time. The stock lacks significant positive catalysts, has weak financial performance, and shows no strong trading signals or bullish sentiment. Holding off on investing in this stock is recommended until stronger indicators emerge.
The MACD histogram is negative and contracting (-0.000812), suggesting bearish momentum. RSI is neutral at 67.335, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level (2.579) with resistance at 2.812 and support at 2.346, showing limited upside potential.
NULL identified. No recent news or events suggest a positive catalyst for the stock. Analysts maintain an Overweight rating but have significantly lowered the price target.
Weak financial performance with no revenue, negative net income (-$44.87M), and declining EPS (-29.03% YoY). The stock's technical indicators and trading trends do not show bullish momentum. Additionally, no recent congress trading data or influential figure activity supports the stock.
In Q3 2025, the company reported no revenue growth, a net loss of $44.87M (improved YoY by 46.48%), and a decline in EPS by 29.03% YoY. Gross margin remains at 0%. The financials indicate poor performance and lack of profitability.
Morgan Stanley maintains an Overweight rating but has lowered the price target from $22 to $14, reflecting reduced expectations for the stock's performance. Analysts remain optimistic about the biotech sector but see limited near-term upside for CABA.
